Dräger's Acute Care System is reported to be the first to offer a totally new approach to managing and delivering care across the entire acute care process - from emergency care to operating theatre, to critical care and neonatal care.
Almost one in three people over 55 will develop congestive heart failure, research has revealed. The Rotterdam Study, a prospective population-based study of cardiovascular and other diseases in the elderly, monitored 7,983 inhabitants of Ommoord, a Rotterdam suburb (source: Eur Heart J 2004: 25, 1614-19).
ST&D is an internationally recognised and leading innovator in targeted vital signs monitoring. It has developed a solution to the issue of remote monitoring with its flexible wireless vital signs platform that can be customised to provide various monitoring products.
A special exhibition in Paderborn's Heinz Nixdorf MuseumsForum (HNF) is demonstrating the use of state-of-the-art computer technology in medical science. With more than 100 exhibits, a third of them interactive, it runs until May 1, 2007. EH correspondent Holger Zorn was one of the first visitors
A pain-free Hospital pilot project launched in Germany three years ago has ended with the first five of 25 hospitals being awarded a Qualified Pain Therapy certification.
A “political agreement” on the EU Health Programme 2007-2013 recently has reached the Health Ministers Council in Brussels. The programme is a framework for the Commission´s funding of projects relating to health and will be part of a broader EU health strategy to be put forward by the Commission next year.
The first five out of a total of 25 German hospitals have just been awarded the certification "Qualified Pain Therapy" with the completion of the pilot project "Pain-free Hospital".
A donation of the antibiotic Cipro® (Bayer HealthCare) with a wholesale value of more than US$ 25 million has been given to the non-profit organization MAP (Medical Assistance Programs) who will distribute it to clinics and hospitals in Africa and Latin America, which suffer badly from the lack of essential drugs.
The Fred easyport, the only pocket defibrillator in the world, which Schiller brought onto the market three years ago, was a huge success so far. From next year on, the device will also supply a manual shock option. It is so small (133 x 126 x 50mm) and light (490 g including the battery) that for many doctors it is already standard equipment in their emergency bag.The fact that this ‘life…
Apparently, 20 children are diagnosed each day in the UK with alcohol poisoning.
Patients with swallowing difficulties could benefit from the new version of the exakt S Tablet Splitter.
Health Manager, a new diagnostic system for personal health monitoring, will be launched by Biocomfort at Medica in November.
Emergency care doctors can now use just one stethoscope to tend either paediatric or adult patients.
Cancer can be tackled with a combination of drug and genetic therapies, so that the effectiveness of individual treatments are enhanced.
Fear for the quality of acute care for the injured and victims of accidents was expressed by Professor Vilmos Vécsei, traumatology and sports traumatology specialist and Head of the University Clinic for Trauma Surgery in Vienna (VV), as well as President and General Secretary of the European Trauma Society (ETS), and Professor Otmar Trentz, Director of the Trauma Surgery Clinic at University…
About 1,600,000 artificial hips are implanted every year, in Germany alone.
Czech Republic - Two unique ophthalmic simulators are in use at the Motol Faculty Hospital, Prague.
New pulsatile heart pumps (ventricular assist devices - VAD) can remain in the body as a permanent heart support.
To meet US requirements, Provotec GmbH & Co KG, of Espelkamp - which is entering US and international markets with their Prognost XPE tables - has increased the patient load and will have UL and CCC approval.
Less bleeding complications due to safe citrate anticoagulation.
The Prismaflex monitor, produced by Gambro Healthcare provides extra therapy options and features for continuous renal replacement therapy.
Continous, non-invasive tissue oxygenation and monitoring during resusciation.
Respironics develops and manufactures innovative sleep and respiratory products and programmes, which it distributes internationally:
Fukuda Denshi, manufacturer of advanced patient monitoring and user-configurable clinical information management systems, recently introduced its popular DS-7100 range of portable, multi-parameter monitors to the European market.
Intersurgical expanded its range of respiratory products.